FDA clears first fully autonomous AI for portable diabetic retinopathy screening
CustomersExpand
IRIS and AEYE Health Announce Partnership to Provide AI Screening to Market
PartnersCustomers
Is ChatGPT Fast Becoming ChatMD? Introducing Generative AI To Healthcare
CustomersPartners
UMass Chan, AEYE Health researching use of AI-based retinal camera screenings in primary care practice
PartnersInvestment
AEYE Health announces best-in-class results, proving AI software is capable of predicting the future development of diabetic retinopathy in patients before diagnosable symptoms manifest
CustomersInvestment
AI Takes Root in Primary Care. First Stop: Diabetic Retinopathy
CustomersExpand
AEYE Health receives FDA clearance for AI-based autonomous screening for referable diabetic retinopathy
Customers
מונעת עיוורון: Aeye Health פיתחה תוכנת AI לאבחון סוכרת דרך הרשתית כלכליסט
CustomersInvestment
AEYE Health Reports Pivotal Clinical Trial Results of its AI Algorithm for the Autonomous Screening and Detection of More-Than-Mild Diabetic Retinopathy
Customers
UMass Medical School and AEYE Health leverage AI to help family doctors screen and refer patients with eye conditions to specialists
PartnersCustomers
BioLight invests in $1m in AEYE Health
Investment
AI screening for diabetic retinopathy
PartnersCustomers
Zack Dvey-Aharon, CEO and Co-Founder of AEYE Health Talks to Pramod Dhakal
PartnersCustomers
The US Government Will Pay Doctors to Use These AI Algorithms
Customers
Diagnosing retinal disease with artificial intelligence
InvestmentPartners
Israeli startup AEYE Health & Optomed join forces, aiming for FDA OK on AI diagnostics tool
Partners
AEYE Health develops advanced AI-based retinal screening with instant results
CustomersPartners
AEYE Health's Simple Eye Scan To Diagnose, Prevent Avoidable Blindness
CustomersPartners
UMass Memorial, Israeli company to collaborate on new solution to prevent avoidable blindness
Partners
Great optics: Israeli innovation scans your eyes to revolutionize disease diagnostics
Investment
